AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 799984 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 28681684 — intervention group
Group type: EXPERIMENTAL
Intervention: Association splitting (AS)
Number of subjects: 120
Study 28681684 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 120
Study 27886064 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplement (1 × 10^10 CFU of multi-species probiotics)
Number of subjects: 33
Study 27886064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 27886064 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplement
Number of subjects: 33
Study 24452372 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session 90-min Acceptance-Based Behavioral Therapy (ABBT) workshop
Number of subjects: 98
Study 24452372 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control condition
Number of subjects: 98
Study 22428464 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg aspirin
Number of subjects: 16
Study 22428464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 22428464 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg aspirin (high HDL group)
Number of subjects: 16
Study 22428464 — intervention group
Group type: COMPARATOR
Intervention: Placebo (high HDL group)
Number of subjects: 16
Study 20862936 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulating the Governor Vessel and Conception Vessel
Number of subjects: 64
Study 20862936 — intervention group
Group type: COMPARATOR
Intervention: Routine needling method
Number of subjects: 64
Study 18490496 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine besylate and olmesartan medoxomil (fixed-dose combination)
Number of subjects: 0
Study 18490496 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy with amlodipine or olmesartan
Number of subjects: 0
Study 18490496 — intervention group
Group type: COMPARATOR
Intervention: Coadministration of amlodipine and olmesartan as separate entities
Number of subjects: 0
Study 18490496 — intervention group
Group type: EXPERIMENTAL
Intervention: Black race as a covariate
Number of subjects: 0
Study 16174115 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic dissection (AD) surgical treatment
Number of subjects: 103
Study 16174115 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic dissection (AD) medical treatment
Number of subjects: 103
Study 16174115 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic intramural hematoma (IMH) follow-up outcomes
Number of subjects: 103
Study 16174115 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-year survival rate
Number of subjects: 103
Study 13130386 — intervention group
Group type: EXPERIMENTAL
Intervention: EGb 761 Ginkgo extract
Number of subjects: 0
Study 11040176 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-mercaptopurine (1.5 mg x kg(‐1) x day(‐1)) + prednisone (40 mg/day)
Number of subjects: 55
Study 11040176 — intervention group
Group type: COMPARATOR
Intervention: Placebo + prednisone (40 mg/day)
Number of subjects: 55
Study 8659328 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 707
Study 8659328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 707
Study 2001777 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (physicians instructed in weight reduction methods)
Number of subjects: 0
Study 2001777 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 0
Study 2001777 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 0
Study 2001777 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 2001777 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Experimental and Control)
Number of subjects: 0
Study 6650576 — intervention group
Group type: EXPERIMENTAL
Intervention: Label EMR (educable mentally retarded)
Number of subjects: 1114
Study 6650576 — intervention group
Group type: EXPERIMENTAL
Intervention: Child's attractiveness and school-related traits
Number of subjects: 1114
Study 31107249 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected individuals with a history of past TB (57 participants)
Number of subjects: 319
Study 31107249 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected individuals (222 participants)
Number of subjects: 319
Study 31107249 — intervention group
Group type: COMPARATOR
Intervention: HIV-uninfected individuals (97 participants)
Number of subjects: 319
Study 30581857 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel®
Number of subjects: 60
Study 30581857 — intervention group
Group type: COMPARATOR
Intervention: Air-Q®
Number of subjects: 60
Study 26871523 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX implant 0.7-mg
Number of subjects: 1048
Study 26871523 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX implant 0.35-mg
Number of subjects: 1048
Study 26871523 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 1048
Study 24178783 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellness program intervention (12-week duration)
Number of subjects: 153
Study 24178783 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 153
Study 21484965 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 or 10 mg/kg every 8 weeks
Number of subjects: 229
Study 21484965 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 or 10 mg/kg
Number of subjects: 229
Study 21484965 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 229
Study 20133962 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT) program, 10-month duration, three 2-hour group sessions per week
Number of subjects: 38
Study 20133962 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 38
Study 18042509 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline Transdermal System (STS) 3 mg/24 h
Number of subjects: 86
Study 18042509 — intervention group
Group type: EXPERIMENTAL
Intervention: Selegiline Transdermal System (STS) 6 mg/24 h
Number of subjects: 86
Study 15882297 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 30
Study 15882297 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 30
Study 15882297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12498526 — intervention group
Group type: COMPARATOR
Intervention: Various pharmacologic therapies (acetaminophen, traditional NSAIDs, COX-2 inhibitors, intra-articular steroids, viscosupplements, glucosamine, chondroitin sulfate, capsaicin)
Number of subjects: 0
Study 12498526 — intervention group
Group type: COMPARATOR
Intervention: Vitamins
Number of subjects: 0
Study 10189601 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week training course on two mnemonic techniques (method of loci for words and name association technique for proper names)
Number of subjects: 268
Study 10189601 — intervention group
Group type: COMPARATOR
Intervention: 2-week training course on two mnemonic techniques
Number of subjects: 268
Study 7757311 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine (Group A)
Number of subjects: 51
Study 7757311 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine and Propranolol (Group B)
Number of subjects: 51
Study 7757311 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydralazine and Pindolol (Group C)
Number of subjects: 51
Study 2323137 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal bone deficiency filled with bone cement (methylmethacrylate)
Number of subjects: 48
Study 2323137 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 48
Study 113626 — intervention group
Group type: COMPARATOR
Intervention: Primary radiation treatment
Number of subjects: 100
Study 113626 — intervention group
Group type: COMPARATOR
Intervention: Primary surgery
Number of subjects: 100
Study 113626 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful radiation for early glottic larynx lesions
Number of subjects: 100
Study 113626 — intervention group
Group type: COMPARATOR
Intervention: Radiation or surgery for supraglottic larynx lesions
Number of subjects: 100
Study 30789432 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal treatment selection rule based on predicted mean difference in outcomes comparing those with versus without treatment, conditional on covariates.
Number of subjects: 0
Study 30789432 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment selection when resources are constrained.
Number of subjects: 0
Study 30789432 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment selection when resources are not constrained.
Number of subjects: 0
Study 30789432 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment selection in the presence of side effects and costs.
Number of subjects: 0
Study 30789432 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment selection to maximize effect heterogeneity.
Number of subjects: 0
Study 28388820 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (methotrexate, sulfasalazine, and hydroxychloroquine)
Number of subjects: 353
Study 28388820 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate-etanercept
Number of subjects: 353
Study 28388820 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 353
Study 28388820 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy and Methotrexate-etanercept
Number of subjects: 353
Study 26640058 — intervention group
Group type: EXPERIMENTAL
Intervention: CVVH-HCO
Number of subjects: 0
Study 26640058 — intervention group
Group type: COMPARATOR
Intervention: CVVH-std
Number of subjects: 0
Study 23592679 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy density (HED) breakfast consumed quickly (FR)
Number of subjects: 20
Study 23592679 — intervention group
Group type: COMPARATOR
Intervention: Low energy density (LED) breakfast consumed slowly (SR)
Number of subjects: 20
Study 23592679 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy density (HED) breakfast consumed slowly (SR)
Number of subjects: 20
Study 23592679 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy density (LED) breakfast consumed quickly (FR)
Number of subjects: 20
Study 23592679 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating rate (ER) manipulation
Number of subjects: 20
Study 23592679 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy density (ED) manipulation
Number of subjects: 20
Study 23592679 — intervention group
Group type: EXPERIMENTAL
Intervention: Active or total ghrelin AUC
Number of subjects: 20
Study 21291517 — intervention group
Group type: EXPERIMENTAL
Intervention: CRASH-1 trial
Number of subjects: 30019
Study 21291517 — intervention group
Group type: COMPARATOR
Intervention: CRASH-2 trial
Number of subjects: 30019
Study 19879683 — intervention group
Group type: EXPERIMENTAL
Intervention: E2/DRSP (17beta‐estradiol 1mg plus drospirenone 2 mg daily)
Number of subjects: 59
Study 19879683 — intervention group
Group type: COMPARATOR
Intervention: E2/NETA (17beta‐estradiol 1mg plus norethisterone acetate 0.5 mg daily)
Number of subjects: 59
Study 17144496 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhino Rapid Nasal Dressing with Gel Knit
Number of subjects: 0
Study 17144496 — intervention group
Group type: COMPARATOR
Intervention: Vaseline gauze
Number of subjects: 0
Study 14716694 — intervention group
Group type: EXPERIMENTAL
Intervention: donepezil+sertraline (50-200 mg)
Number of subjects: 144
Study 14716694 — intervention group
Group type: EXPERIMENTAL
Intervention: donepezil+sertraline
Number of subjects: 144
Study 14716694 — intervention group
Group type: COMPARATOR
Intervention: donepezil+placebo
Number of subjects: 144
Study 11387489 — intervention group
Group type: EXPERIMENTAL
Intervention: Power transcranial color duplex sonography (power TCDS)
Number of subjects: 171
Study 9759799 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (target STC of 10 to 15 mg/L)
Number of subjects: 12
Study 9759799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8169705 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexital
Number of subjects: 40
Study 8169705 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40
Study 3348159 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms phylloquinone/d for 12 d
Number of subjects: 10
Study 3348159 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 micrograms phylloquinone/d for 12 d
Number of subjects: 10
Study 3348159 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K restriction
Number of subjects: 10
Study 3348159 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms phylloquinone/d and 500 micrograms phylloquinone/d
Number of subjects: 10
Study 30148973 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (3 sets of 10 min with 80%-90% of maximum heart rate)
Number of subjects: 44
Study 30148973 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (4 sets of 8 repetitions with 80% of 1-repetition maximum)
Number of subjects: 44
Study 30148973 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent training (combination of endurance and resistance training)
Number of subjects: 44
Study 30148973 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 29124831 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical triamcinolone acetonide 0.1% oral paste
Number of subjects: 45
Study 29124831 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methotrexate
Number of subjects: 45
Study 29124831 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of topical triamcinolone acetonide 0.1% and oral methotrexate
Number of subjects: 45
Study 27895475 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 21
Study 27895475 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 21
Study 25044085 — intervention group
Group type: EXPERIMENTAL
Intervention: Enclomiphene citrate
Number of subjects: 0
Study 25044085 — intervention group
Group type: COMPARATOR
Intervention: Topical testosterone gel (1% T gel)
Number of subjects: 0
Study 23170814 — intervention group
Group type: EXPERIMENTAL
Intervention: TOC communication tool
Number of subjects: 1400
Study 23170814 — intervention group
Group type: COMPARATOR
Intervention: Traditional dictated summary
Number of subjects: 1400
Study 20864808 — intervention group
Group type: EXPERIMENTAL
Intervention: Active vaccine (DNA prime, recombinant fowlpox virus boost)
Number of subjects: 8
Study 20864808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 17363185 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel (Intrasite)
Number of subjects: 357
Study 17363185 — intervention group
Group type: COMPARATOR
Intervention: Dry dressings (Tricotex)
Number of subjects: 357
Study 15080407 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone 50 mg/kg
Number of subjects: 75
Study 15080407 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone 75 mg/kg
Number of subjects: 75
Study 15080407 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chelator)
Number of subjects: 75
Study 11085324 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (50 to 150 mg)
Number of subjects: 0
Study 9193364 — intervention group
Group type: EXPERIMENTAL
Intervention: MOPP/ABV hybrid regimen
Number of subjects: 301
Study 9193364 — intervention group
Group type: COMPARATOR
Intervention: Alternating MOPP/ABVD
Number of subjects: 301
Study 8173687 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine-Metoprolol 10/100 mg
Number of subjects: 159
Study 8173687 — intervention group
Group type: COMPARATOR
Intervention: Felodipine 10 mg
Number of subjects: 159
Study 8173687 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol 100 mg
Number of subjects: 159
Study 3781686 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (16 g/day)
Number of subjects: 12
Study 3781686 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (1 g/day)
Number of subjects: 12
Study 3781686 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol + Cholestyramine
Number of subjects: 12
Study 3781686 — intervention group
Group type: COMPARATOR
Intervention: Cholestyramine
Number of subjects: 12
Study 3781686 — intervention group
Group type: COMPARATOR
Intervention: Probucol
Number of subjects: 12
Study 3781686 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Probucol + Cholestyramine)
Number of subjects: 12
Study 3235476 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan (single dose)
Number of subjects: 12
Study 3235476 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan (chronic treatment)
Number of subjects: 12
Study 3235476 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (steady state)
Number of subjects: 12
Study 3235476 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3235476 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 12
Study 3235476 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 12
Study 31288849 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training exercise (muscle strength training, balance training, knee joint proprioception training)
Number of subjects: 60
Study 31288849 — intervention group
Group type: COMPARATOR
Intervention: Taping (using 'Y' and 'I' type taping)
Number of subjects: 60
Study 31288849 — intervention group
Group type: COMPARATOR
Intervention: Health education (education lectures once a week for three months)
Number of subjects: 60
Study 31288849 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular training exercise
Number of subjects: 60
Study 31288849 — intervention group
Group type: COMPARATOR
Intervention: Taping
Number of subjects: 60
Study 31288849 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 60
Study 28362054 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% cyclosporine A cationic emulsion (CsA CE)
Number of subjects: 489
Study 25445400 — intervention group
Group type: EXPERIMENTAL
Intervention: simeprevir plus peginterferon/ribavirin (PR)
Number of subjects: 2007
Study 23374200 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial electric stimulation (active device) for 60 minutes for five days
Number of subjects: 0
Study 23374200 — intervention group
Group type: COMPARATOR
Intervention: Sham device (placebo control) for 60 minutes for five days
Number of subjects: 0
Study 21641516 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogic practices (35-40 min/day, five days a week for six months)
Number of subjects: 170
Study 18033724 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Music Engagement (AME)
Number of subjects: 83
Study 18033724 — intervention group
Group type: COMPARATOR
Intervention: Music Listening (ML)
Number of subjects: 83
Study 18033724 — intervention group
Group type: COMPARATOR
Intervention: Audio Storybooks (ASB)
Number of subjects: 83
Study 16813785 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic environment
Number of subjects: 27
Study 16813785 — intervention group
Group type: COMPARATOR
Intervention: Suburban street environment
Number of subjects: 27
Study 16813785 — intervention group
Group type: COMPARATOR
Intervention: Shopping mall environment
Number of subjects: 27
Study 16813785 — intervention group
Group type: EXPERIMENTAL
Intervention: No task
Number of subjects: 27
Study 16813785 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor task
Number of subjects: 27
Study 16813785 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive task
Number of subjects: 27
Study 15545155 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS
Number of subjects: 1498
Study 15545155 — intervention group
Group type: COMPARATOR
Intervention: Co‐amilozide (diuretic combination)
Number of subjects: 1498
Study 11554954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg
Number of subjects: 660
Study 11554954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 660
Study 11554954 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 660
Study 11554954 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg and 400 mg
Number of subjects: 660
Study 10740725 — intervention group
Group type: EXPERIMENTAL
Intervention: Y virilin (Treatment Group A)
Number of subjects: 52
Study 10740725 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Treatment Group B)
Number of subjects: 52
Study 10740725 — intervention group
Group type: EXPERIMENTAL
Intervention: Y virilin (for azospermic patients)
Number of subjects: 52
Study 10740725 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for azospermic patients)
Number of subjects: 52
Study 8296075 — intervention group
Group type: EXPERIMENTAL
Intervention: MNSs system segregation distortions among mothers
Number of subjects: 400
Study 8296075 — intervention group
Group type: EXPERIMENTAL
Intervention: Ss heterozygotes
Number of subjects: 400
Study 8296075 — intervention group
Group type: COMPARATOR
Intervention: Subsamples from different hospitals
Number of subjects: 400
Study 3726800 — intervention group
Group type: EXPERIMENTAL
Intervention: PROPLEX
Number of subjects: 0
Study 3726800 — intervention group
Group type: COMPARATOR
Intervention: PROPLEX SX
Number of subjects: 0
Study 29559834 — intervention group
Group type: COMPARATOR
Intervention: Oral Ibuprofen (OI) for 6 weeks
Number of subjects: 105
Study 29559834 — intervention group
Group type: EXPERIMENTAL
Intervention: Median Nerve Neural Mobilization (MNNM)
Number of subjects: 105
Study 29559834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Lateral Glide (CLG)
Number of subjects: 105
Study 29559834 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (MNNM, CLG, OI)
Number of subjects: 105
Study 27081873 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT) [λ=640 nm, SAEF=1.06 J/cm²]
Number of subjects: 120
Study 27081873 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-Emitting Diode (LED) [λ=660±20 nm, SAEF=0.24 J/cm²]
Number of subjects: 120
Study 27081873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 27081873 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study 25623934 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 1mg
Number of subjects: 30